FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
We are seeking a Biochemist/Crystallographer to crystallize protein-drug complexes.
Requirements are a PhD in Biochemistry, Structural Biology or related Field. Postdoc experience is optional. First author publication in a relevant journal is required.
The successful candidate for this position will be a highly motivated individual who can communicate effectively, contribute beyond their strict discipline, be flexible and responsive to the changing needs of a dynamic entrepreneurial organization and fit well in small agile biotech team.
FoRx Therapeutics encourages and supports a diverse work environment as an Equal Opportunity Employer, offers a stimulating work environment and a competitive compensation package.
Interested candidates should send a cover letter describing research interests and career goals, along with a Curriculum Vitae to:
Please feel free to contact me directly.
Sotirios K. Sotiriou, PhD
Head of Biology, FoRx Therapeutics
WSJ-350.2.03, Novartis Campus
CH-4056 Basel, Switzerland
Tel: +41 (0) 788733686
To unsubscribe from the CCP4BB list, click the following link: